The Right Way to Sell Chips to China
Current export rules focus on keeping chips a generation behind. They should focus on keeping America's total compute ahead.
The Robot in Your Living Room Has No Rulebook
Embodied AI is arriving faster than the regulations meant to govern it. If we start now, that’s a problem we can still fix.
How AI Could Benefit Workers, Even If It Displaces Most Jobs
AI is already taking jobs, but that is only one facet of its complex economic effects. Price dynamics and bottlenecks indicate that automation could be good news for workers — but only if it vastly outperforms them.
China and the US Are Running Different AI Races
Shaped by a different economic environment, China’s AI startups are optimizing for different customers than their US counterparts — and seeing faster industrial adoption.
High-Bandwidth Memory: The Critical Gaps in US Export Controls
Modern memory architecture is vital for advanced AI systems. While the US leads in both production and innovation, significant gaps in export policy are helping China catch up.
Making Extreme AI Risk Tradeable
Traditional insurance can’t handle the extreme risks of frontier AI. Catastrophe bonds can cover the gap and compel labs to adopt tougher safety standards.
Exporting Advanced Chips Is Good for Nvidia, Not the US
The White House is betting that hardware sales will buy software loyalty — a strategy borrowed from 5G that misunderstands how AI actually works.
AI Could Undermine Emerging Economies
AI automation threatens to erode the “development ladder,” a foundational economic pathway that has lifted hundreds of millions out of poverty.
Stay informed on the future of AI alongside
other subscribers
- Chatbots give dangerous bio-weapon advice: AI models provided detailed, actionable biological weapon instructions.
- Safety guardrails often insufficient: Current AI safeguards can be bypassed or are inconsistently applied.
- Expert misuse is a major concern: Skilled actors could exploit AI for real-world biothreats.
- Balancing innovation and risk is urgent: AI's benefits in medicine must be weighed against biosecurity dangers.
- Musk sues OpenAI, Altman, Microsoft: Claims betrayal of non-profit AI mission.
- Trial spotlights AGI race stakes: Outcome could shift AI industry power balance.
- Motives and credibility questioned: Both sides accused of self-interest, not altruism.
- Public impact and AI governance: Trial may influence future AI development oversight.
- Rapid AI weapon adoption: Military rushed AI into use before ethical debate.
- Project Maven’s secretive origins: Small team covertly advanced battlefield AI targeting.
- Real-world impact in Ukraine, Gaza: AI enabled mass targeting, raising civilian risk concerns.
- Ongoing ethical dilemmas: Debate persists over autonomy, reliability, and human oversight.